retatrutide developer eli lilly shares safety, tolerability data on its next-gen obesity drug Lilly's triple agonist achieves 16.8%
Pay in 4 interest-free payments of $5.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12























